What changed from existing technology?
This study introduces a digital platform designed to make clinical trials more efficient and reliable by creating a clear, verifiable chain of evidence throughout the trial process.
The platform introduces a novel approach to clinical trials by creating a traceable and verifiable evidence chain, which enhances auditability and reduces data transcription errors.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 2
orting decentralized clinical trials: architecture and real-world evaluation. Decentralized clinical trials (DCTs) can improve participant accessibility and tri
Title ↗idence-chain digital platform supporting decentralized clinical trials: architecture and real-world evaluation. Decentralized clinical trials (DCTs) can improve par
Title ↗- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This platform could be used to improve the efficiency and reliability of clinical trials by reducing data transcription errors and enhancing auditability.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.